| Early dynamics of transmission and control of COVID-19: a mathematical modelling study AJ Kucharski, TW Russell, C Diamond, Y Liu, J Edmunds, S Funk, ... The lancet infectious diseases 20 (5), 553-558, 2020 | 1374 | 2020 |
| Feasibility of controlling COVID-19 outbreaks by isolation of cases and contacts J Hellewell, S Abbott, A Gimma, NI Bosse, CI Jarvis, TW Russell, ... The Lancet Global Health 8 (4), e488-e496, 2020 | 1274 | 2020 |
| The effect of control strategies to reduce social mixing on outcomes of the COVID-19 epidemic in Wuhan, China: a modelling study K Prem, Y Liu, TW Russell, AJ Kucharski, RM Eggo, N Davies, S Flasche, ... The Lancet Public Health 5 (5), e261-e270, 2020 | 1008 | 2020 |
| Age-dependent effects in the transmission and control of COVID-19 epidemics NG Davies, P Klepac, Y Liu, K Prem, M Jit, RM Eggo Nature medicine 26 (8), 1205-1211, 2020 | 444 | 2020 |
| Modeling infectious disease dynamics in the complex landscape of global health H Heesterbeek, RM Anderson, V Andreasen, S Bansal, D De Angelis, ... Science 347 (6227), 2015 | 385 | 2015 |
| Effects of non-pharmaceutical interventions on COVID-19 cases, deaths, and demand for hospital services in the UK: a modelling study NG Davies, AJ Kucharski, RM Eggo, A Gimma, WJ Edmunds, T Jombart, ... The Lancet Public Health 5 (7), e375-e385, 2020 | 229 | 2020 |
| Effectiveness of isolation, testing, contact tracing, and physical distancing on reducing transmission of SARS-CoV-2 in different settings: a mathematical modelling study AJ Kucharski, P Klepac, AJK Conlan, SM Kissler, ML Tang, H Fry, JR Gog, ... The Lancet Infectious Diseases 20 (10), 1151-1160, 2020 | 213 | 2020 |
| Quantifying the impact of physical distance measures on the transmission of COVID-19 in the UK CI Jarvis, K Van Zandvoort, A Gimma, K Prem, P Klepac, GJ Rubin, ... BMC medicine 18, 1-10, 2020 | 205 | 2020 |
| Global, regional, and national estimates of the population at increased risk of severe COVID-19 due to underlying health conditions in 2020: a modelling study A Clark, M Jit, C Warren-Gash, B Guthrie, HHX Wang, SW Mercer, ... The Lancet Global Health 8 (8), e1003-e1017, 2020 | 203 | 2020 |
| Nine challenges in incorporating the dynamics of behaviour in infectious diseases models S Funk, S Bansal, CT Bauch, KTD Eames, WJ Edmunds, AP Galvani, ... Epidemics 10, 21-25, 2015 | 119 | 2015 |
| Centre for the Mathematical Modelling of Infectious Diseases COVID-19 Working Group. Feasibility of controlling COVID-19 outbreaks by isolation of cases and contacts J Hellewell, S Abbott, A Gimma, NI Bosse, CI Jarvis, TW Russell, ... Lancet Glob Health 8 (4), e488-e496, 2020 | 111 | 2020 |
| Towards the endgame and beyond: complexities and challenges for the elimination of infectious diseases P Klepac, CJE Metcalf, AR McLean, K Hampson Philosophical Transactions of the Royal Society B: Biological Sciences 368 …, 2013 | 104 | 2013 |
| Impact of birth rate, seasonality and transmission rate on minimum levels of coverage needed for rubella vaccination CJE Metcalf, J Lessler, P Klepac, F Cutts, BT Grenfell Epidemiology & Infection 140 (12), 2290-2301, 2012 | 64 | 2012 |
| Centre for the Mathematical Modelling of Infectious Diseases COVID-19 Working Group, The effect of control strategies to reduce social mixing on outcomes of the COVID-19 … K Prem, Y Liu, TW Russell, AJ Kucharski, RM Eggo, N Davies, M Jit, ... Lancet Public Health 5 (5), e261-e270, 2020 | 59 | 2020 |
| Patterns of human social contact and contact with animals in Shanghai, China J Zhang, P Klepac, JM Read, A Rosello, X Wang, S Lai, M Li, Y Song, ... Scientific reports 9 (1), 1-11, 2019 | 58 | 2019 |
| Stabilizing dispersal delays in predator–prey metapopulation models MG Neubert, P Klepac, P Van Den Driessche Theoretical population biology 61 (3), 339-347, 2002 | 57 | 2002 |
| The stage-structured epidemic: linking disease and demography with a multi-state matrix approach model P Klepac, H Caswell Theoretical Ecology 4 (3), 301-319, 2011 | 55 | 2011 |
| Routine childhood immunisation during the COVID-19 pandemic in Africa: a benefit–risk analysis of health benefits versus excess risk of SARS-CoV-2 infection K Abbas, SR Procter, K van Zandvoort, A Clark, S Funk, T Mengistu, ... The Lancet Global Health 8 (10), e1264-e1272, 2020 | 54 | 2020 |
| Synthesizing epidemiological and economic optima for control of immunizing infections P Klepac, R Laxminarayan, BT Grenfell Proceedings of the National Academy of Sciences 108 (34), 14366-14370, 2011 | 47 | 2011 |
| The epidemiology of rubella in Mexico: seasonality, stochasticity and regional variation CJE Metcalf, ON Bjørnstad, MJ Ferrari, P Klepac, N Bharti, H Lopez-Gatell, ... Epidemiology & Infection 139 (7), 1029-1038, 2011 | 45 | 2011 |
